Cite
428 TARGETED NEXT-GENERATION SEQUENCING (NGS) OF BILIARY BRUSHINGS AND BIOPSIES IMPROVES THE DETECTION OF MALIGNANT STRICTURES AND POTENTIALLY STRATIFIES PATIENTS FOR TARGETED ANTICANCER THERAPY
MLA
Savreet Sarkaria, et al. “428 Targeted Next-Generation Sequencing (Ngs) of Biliary Brushings and Biopsies Improves the Detection of Malignant Strictures and Potentially Stratifies Patients for Targeted Anticancer Therapy.” Gastrointestinal Endoscopy, vol. 91, June 2020, pp. AB39-AB40. EBSCOhost, https://doi.org/10.1016/j.gie.2020.03.283.
APA
Savreet Sarkaria, Carl Schmidt, Randall E. Brand, Adam Slivka, John Nasr, David L. Bartlett, Rohit Das, Harkirat Singh, Abigail I. Wald, Nathan Bahary, Mordechai Rabinovitz, David A. Geller, Kenneth K.W. Lee, Aatur D. Singhi, Anna Tavakkoli, Herbert J. Zeh, J. Wallis Marsh, Abhinav Humar, Asif Khalid, … Fasanella Kenneth. (2020). 428 Targeted Next-Generation Sequencing (Ngs) of Biliary Brushings and Biopsies Improves the Detection of Malignant Strictures and Potentially Stratifies Patients for Targeted Anticancer Therapy. Gastrointestinal Endoscopy, 91, AB39-AB40. https://doi.org/10.1016/j.gie.2020.03.283
Chicago
Savreet Sarkaria, Carl Schmidt, Randall E. Brand, Adam Slivka, John Nasr, David L. Bartlett, Rohit Das, et al. 2020. “428 Targeted Next-Generation Sequencing (Ngs) of Biliary Brushings and Biopsies Improves the Detection of Malignant Strictures and Potentially Stratifies Patients for Targeted Anticancer Therapy.” Gastrointestinal Endoscopy 91 (June): AB39-AB40. doi:10.1016/j.gie.2020.03.283.